Bay Street News, 2024

New York, NY, Aug. 30, 2024 (GLOBE NEWSWIRE) — Qomolangma Acquisition Corp. (Nasdaq: QOMO) (the “Company”) announced that it has […]

SAN DIEGO, Aug. 30, 2024 (GLOBE NEWSWIRE) —  Ventyx Biosciences, Inc. (Nasdaq: VTYX) (“Ventyx”), a clinical-stage biopharmaceutical company focused on […]

STOUGHTON, Mass., Aug. 30, 2024 (GLOBE NEWSWIRE) — Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading, diversified specialty pharmaceutical company committed to […]

SOUTH SAN FRANCISCO, Calif., Aug. 30, 2024 (GLOBE NEWSWIRE) — Vaxart, Inc. (Nasdaq: VXRT) (the “Company” or “Vaxart”) today announced […]

WATERTOWN, Mass., Aug. 30, 2024 (GLOBE NEWSWIRE) — Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, […]

TORONTO, Aug. 30, 2024 (GLOBE NEWSWIRE) — Mulvihill Premium Yield Fund (the “Fund”) (TSX: MPY) announces results of operations for […]

TORONTO, Aug. 30, 2024 (GLOBE NEWSWIRE) — (TSX: XLVE) Mulvihill U.S. Health Care Enhanced Yield ETF (the “Fund”) announces results […]

TORONTO, Aug. 30, 2024 (GLOBE NEWSWIRE) — (TSX: CBNK) Mulvihill Canadian Bank Enhanced Yield ETF (the “Fund”) announces results of […]

TORONTO, Aug. 30, 2024 (GLOBE NEWSWIRE) — — (TSX: TXT.UN; TXT.PR.A) — Top 10 Split Trust (the “Fund”) announces results of […]

TORONTO, Aug. 30, 2024 (GLOBE NEWSWIRE) — CHAR Technologies (“CHAR Tech” or the “Company”) (TSXV:YES), a leader in sustainable energy […]